AI Visibility Scorecard
Taking RINVOQ® (upadacitinib) for Ulcerative Colitis
takinguctreatment.com · Healthcare
At 1.97/10, Taking RINVOQ® (upadacitinib) for Ulcerative Colitis is near-invisible in AI search today. Most AI engines will not name it when asked about its category. The weakest signals are Structured Data, Backlinks and Domain Trust. That is fixable, and the signals below show where to start.
AI engines read this profile 7 times
Apple Intelligence · Meta AI · Perplexity
6
AI Naming Predictability
iRarely named · 6/100
Healthcare average 11
Top 67% of Healthcare
See what's behind this score →1.97
-
Network Authority
iNot connected yet
0 relationships on record. Businesses in Healthcare average 3. Claim your page and Engagemii is your first.
See what's behind this score →30
Muse Index Score
iAI agent readiness
Agent-ready · 30/100
Healthcare average 18
See what's behind this score →0
About Taking RINVOQ® (upadacitinib) for Ulcerative Colitis
from our crawl and measurement
Taking RINVOQ® (upadacitinib) for Ulcerative Colitis is a business whose own site puts it this way: "RINVOQ is a once-daily pill for adults with moderate to severe Ulcerative Colitis. The recommended starting dose for RINVOQ is 45mg once a day for 8 weeks." To AI engines like ChatGPT and Perplexity, though, it is barely visible: it scores 1.97 out of 10.
Our crawl found structured data on the page (MedicalWebPage) and a readable heading structure. It is missing an llms.txt file and a sitemap.
AI crawlers have read this profile 7 times in our tracking, including Applebot (Siri), Meta AI and PerplexityBot.
- Company ·
- Taking RINVOQ® (upadacitinib) for Ulcerative Colitis
- Website ·
- takinguctreatment.com
- Industry ·
- Healthcare
- Site status ·
- Live (The website showed an active business site when last checked (Oct 31, 2026).)
- Last scored ·
- Nov 9, 2026
The 6 on-page signals AI reads
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Good
Sitemaps and entity links AI can follow.
The 6 off-page signals AI reads
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
-
Not yet measured.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can read your site and name it in answers. At 1.97/10, Taking RINVOQ® (upadacitinib) for Ulcerative Colitis is near-invisible to AI engines today. That is fixable, and the signals above are where to start.
Frequently Asked Questions
How to take RINVOQ?
Take one pill, once a day RINVOQ can be taken with or without food. Avoid food or drink containing grapefruit. Do not split, crush, or chew the pill Call your healthcare provider if you see medication residue (a whole tablet or tablet pieces) in your stool. RINVOQ is a once-daily pill, not an infusion or injection.
Why your brand doesn't show up in ChatGPT answers (and how to fix it)
ChatGPT doesn't crawl the web like Google does. When someone asks Claude about the best project management tools, the model isn't searching your website in real-time. It's pulling from training data that stopped months or years ago.
Continue reading in your free Engagemii portalSign up free to read the full article and get your AEO fix list for Taking RINVOQ® (upadacitinib) for Ulcerative Colitis.
Source & Attribution
Scored by Engagemii on November 9, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/takinguctreatment
Cite this score: Engagemii (2026). "AEO Score for Taking RINVOQ® (upadacitinib) for Ulcerative Colitis." Retrieved from https://engagemii.com/aeo/brands/takinguctreatment
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform